{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,2,10]],"date-time":"2024-02-10T00:25:25Z","timestamp":1707524725751},"reference-count":27,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,8,21]]},"DOI":"10.7759\/cureus.28223","type":"journal-article","created":{"date-parts":[[2022,8,21]],"date-time":"2022-08-21T10:27:31Z","timestamp":1661077651000},"source":"Crossref","is-referenced-by-count":0,"title":["Patterns of Care and Utilization of Radiation for Women With Good-Risk Ductal Carcinoma In Situ: A National Cancer Database Analysis"],"prefix":"10.7759","author":[{"given":"Benjamin","family":"Silver","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Mattessich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Irini","family":"Yacoub","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Schreiber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20979","article-title":"Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study","volume":"103","author":"Collins LC","year":"2005","unstructured":"Collins LC, Tamimi RM, Baer HJ, Connolly JL, Colditz GA, Schnitt SJ. Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy: results from the Nurses' Health Study. Cancer. 2005, 103:1778-84. 10.1002\/cncr.20979","journal-title":"Cancer"},{"key":"ref2","unstructured":"National Comprehensive Cancer Network Breast Cancer (version 3.2022). (2022). Accessed. August 21, 2022: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/breast.pdf."},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD000563.pub7","article-title":"Post-operative radiotherapy for ductal carcinoma in situ of the breast","author":"Goodwin A","year":"2013","unstructured":"Goodwin A, Parker S, Ghersi D, Wilcken N. Post-operative radiotherapy for ductal carcinoma in situ of the breast. Cochrane Database Syst Rev. 2013, CD000563. 10.1002\/14651858.CD000563.pub7","journal-title":"Cochrane Database Syst Rev"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1998.16.2.441","article-title":"Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17","volume":"16","author":"Fisher B","year":"1998","unstructured":"Fisher B, Dignam J, Wolmark N, et al.. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol. 1998, 16:441-52. 10.1200\/JCO.1998.16.2.441","journal-title":"J Clin Oncol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(99)06341-2","article-title":"Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853","volume":"355","author":"Julien J-P","year":"2000","unstructured":"Julien J-P, Bijker N, Fentiman IS, et al.. Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: first results of the EORTC randomised phase III trial 10853. Lancet. 2000, 355:528-33. 10.1016\/s0140-6736(99)06341-2","journal-title":"Lancet"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1080\/02841860600681569","article-title":"SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening","volume":"45","author":"Emdin SO","year":"2006","unstructured":"Emdin SO, Granstrand B, Ringberg A, et al.. SweDCIS: radiotherapy after sector resection for ductal carcinoma in situ of the breast. Results of a randomised trial in a population offered mammography screening. Acta Oncol. 2006, 45:536-43. 10.1080\/02841860600681569","journal-title":"Acta Oncol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(10)70266-7","article-title":"Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial","volume":"12","author":"Cuzick J","year":"2011","unstructured":"Cuzick J, Sestak I, Pinder SE, et al.. Effect of tamoxifen and radiotherapy in women with locally excised ductal carcinoma in situ: long-term results from the UK\/ANZ DCIS trial. Lancet Oncol. 2011, 12:21-9. 10.1016\/S1470-2045(10)70266-7","journal-title":"Lancet Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.60.8588","article-title":"Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study","volume":"33","author":"Solin LJ","year":"2015","unstructured":"Solin LJ, Gray R, Hughes LL, et al.. Surgical excision without radiation for ductal carcinoma in situ of the breast: 12-year results from the ECOG-ACRIN E5194 study. J Clin Oncol. 2015, 33:3938-44. 10.1200\/JCO.2015.60.8588","journal-title":"J Clin Oncol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.57.9029","article-title":"RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation","volume":"33","author":"McCormick B","year":"2015","unstructured":"McCormick B, Winter K, Hudis C, et al.. RTOG 9804: a prospective randomized trial for good-risk ductal carcinoma in situ comparing radiotherapy with observation. J Clin Oncol. 2015, 33:709-15. 10.1200\/JCO.2014.57.9029","journal-title":"J Clin Oncol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.21.01083","article-title":"Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from NRG Oncology\/RTOG 9804","volume":"39","author":"McCormick B","year":"2021","unstructured":"McCormick B, Winter KA, Woodward W, et al.. Randomized phase III trial evaluating radiation following surgical excision for good-risk ductal carcinoma in situ: long-term report from NRG Oncology\/RTOG 9804. J Clin Oncol. 2021, 39:3574-82. 10.1200\/JCO.21.01083","journal-title":"J Clin Oncol"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.8847","article-title":"Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ","volume":"28","author":"Rudloff U","year":"2010","unstructured":"Rudloff U, Jacks LM, Goldberg JI, Wynveen CA, Brogi E, Patil S, Van Zee KJ. Nomogram for predicting the risk of local recurrence after breast-conserving surgery for ductal carcinoma in situ. J Clin Oncol. 2010, 28:3762-9. 10.1200\/JCO.2009.26.8847","journal-title":"J Clin Oncol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djt067","article-title":"A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast","volume":"105","author":"Solin LJ","year":"2013","unstructured":"Solin LJ, Gray R, Baehner FL, et al.. A multigene expression assay to predict local recurrence risk for ductal carcinoma in situ of the breast. J Natl Cancer Inst. 2013, 105:701-10. 10.1093\/jnci\/djt067","journal-title":"J Natl Cancer Inst"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-18-0842","article-title":"A biological signature for breast ductal carcinoma in situ to predict radiotherapy benefit and assess recurrence risk","volume":"24","author":"Bremer T","year":"2018","unstructured":"Bremer T, Whitworth PW, Patel R, et al.. A biological signature for breast ductal carcinoma in situ to predict radiotherapy benefit and assess recurrence risk. Clin Cancer Res. 2018, 24:5895-901. 10.1158\/1078-0432.CCR-18-0842","journal-title":"Clin Cancer Res"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djn344","article-title":"Recent trends in breast cancer among younger women in the United States","volume":"100","author":"Brinton LA","year":"2008","unstructured":"Brinton LA, Sherman ME, Carreon JD, Anderson WF. Recent trends in breast cancer among younger women in the United States. J Natl Cancer Inst. 2008, 100:1643-8. 10.1093\/jnci\/djn344","journal-title":"J Natl Cancer Inst"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1093\/jnci\/djp482","article-title":"Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes","volume":"102","author":"Virnig BA","year":"2010","unstructured":"Virnig BA, Tuttle TM, Shamliyan T, Kane RL. Ductal carcinoma in situ of the breast: a systematic review of incidence, treatment, and outcomes. J Natl Cancer Inst. 2010, 102:170-8. 10.1093\/jnci\/djp482","journal-title":"J Natl Cancer Inst"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61629-2","article-title":"Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials","volume":"378","author":"Darby S","year":"2011","unstructured":"Darby S, McGale P, Correa C, et al.. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10,801 women in 17 randomised trials. Lancet. 2011, 378:1707-16. 10.1016\/S0140-6736(11)61629-2","journal-title":"Lancet"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(14)71221-5","article-title":"Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial","volume":"16","author":"Kunkler IH","year":"2015","unstructured":"Kunkler IH, Williams LJ, Jack WJL, Cameron DA, Dixon JM, PRIME II investigators. Breast-conserving surgery with or without irradiation in women aged 65 years or older with early breast cancer (PRIME II): a randomised controlled trial. Lancet Oncol. 2015, 16:266-73. 10.1016\/S1470-2045(14)71221-5","journal-title":"Lancet Oncol"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.2615","article-title":"Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343","volume":"31","author":"Hughes KS","year":"2013","unstructured":"Hughes KS, Schnaper LA, Bellon JR, et al.. Lumpectomy plus tamoxifen with or without irradiation in women age 70 years or older with early breast cancer: long-term follow-up of CALGB 9343. J Clin Oncol. 2013, 31:2382-7. 10.1200\/JCO.2012.45.2615","journal-title":"J Clin Oncol"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.34.0141","article-title":"Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24","volume":"30","author":"Allred DC","year":"2012","unstructured":"Allred DC, Anderson SJ, Paik S, et al.. Adjuvant tamoxifen reduces subsequent breast cancer in women with estrogen receptor-positive ductal carcinoma in situ: a study based on NSABP protocol B-24. J Clin Oncol. 2012, 30:1268-73. 10.1200\/JCO.2010.34.0141","journal-title":"J Clin Oncol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.prro.2018.01.012","article-title":"Radiation therapy for the whole breast: executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline","volume":"8","author":"Smith BD","year":"2018","unstructured":"Smith BD, Bellon JR, Blitzblau R, et al.. Radiation therapy for the whole breast: executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based guideline. Pract Radiat Oncol. 2018, 8:145-52. 10.1016\/j.prro.2018.01.012","journal-title":"Pract Radiat Oncol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(19)32514-0","article-title":"Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial","volume":"394","author":"Vicini FA","year":"2019","unstructured":"Vicini FA, Cecchini RS, White JR, et al.. Long-term primary results of accelerated partial breast irradiation after breast-conserving surgery for early-stage breast cancer: a randomised, phase 3, equivalence trial. Lancet. 2019, 394:2155-64. 10.1016\/S0140-6736(19)32514-0","journal-title":"Lancet"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(19)32515-2","article-title":"External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial","volume":"394","author":"Whelan TJ","year":"2019","unstructured":"Whelan TJ, Julian JA, Berrang TS, et al.. External beam accelerated partial breast irradiation versus whole breast irradiation after breast conserving surgery in women with ductal carcinoma in situ and node-negative breast cancer (RAPID): a randomised controlled trial. Lancet. 2019, 394:2165-72. 10.1016\/s0140-6736(19)32515-2","journal-title":"Lancet"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)31145-5","article-title":"Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial","volume":"390","author":"Coles CE","year":"2017","unstructured":"Coles CE, Griffin CL, Kirby AM, et al.. Partial-breast radiotherapy after breast conservation surgery for patients with early breast cancer (UK IMPORT LOW trial): 5-year results from a multicentre, randomised, controlled, phase 3, non-inferiority trial. Lancet. 2017, 390:1048-60. 10.1016\/S0140-6736(17)31145-5","journal-title":"Lancet"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.20.00650","article-title":"Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-Florence trial","volume":"38","author":"Meattini I","year":"2020","unstructured":"Meattini I, Marrazzo L, Saieva C, et al.. Accelerated partial-breast irradiation compared with whole-breast irradiation for early breast cancer: long-term results of the randomized phase III APBI-IMRT-Florence trial. J Clin Oncol. 2020, 38:4175-83. 10.1200\/JCO.20.00650","journal-title":"J Clin Oncol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(10)60837-9","article-title":"Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial","volume":"376","author":"Vaidya JS","year":"2010","unstructured":"Vaidya JS, Joseph DJ, Tobias JS, et al.. Targeted intraoperative radiotherapy versus whole breast radiotherapy for breast cancer (TARGIT-A trial): an international, prospective, randomised, non-inferiority phase 3 trial. Lancet. 2010, 376:91-102. 10.1016\/s0140-6736(10)60837-9","journal-title":"Lancet"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2011.06.026","article-title":"First results of the randomised UK FAST trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE\/04\/015)","volume":"100","author":"Agrawal RK","year":"2011","unstructured":"Agrawal RK, Alhasso A, Barrett-Lee PJ, et al.. First results of the randomised UK FAST trial of radiotherapy hypofractionation for treatment of early breast cancer (CRUKE\/04\/015). Radiother Oncol. 2011, 100:93-100. 10.1016\/j.radonc.2011.06.026","journal-title":"Radiother Oncol"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30932-6","article-title":"Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial","volume":"395","author":"Murray Brunt A","year":"2020","unstructured":"Murray Brunt A, Haviland JS, Wheatley DA, et al.. Hypofractionated breast radiotherapy for 1 week versus 3 weeks (FAST-Forward): 5-year efficacy and late normal tissue effects results from a multicentre, non-inferiority, randomised, phase 3 trial. Lancet. 2020, 395:1613-26. 10.1016\/S0140-6736(20)30932-6","journal-title":"Lancet"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/97718-patterns-of-care-and-utilization-of-radiation-for-women-with-good-risk-ductal-carcinoma-in-situ-a-national-cancer-database-analysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:39:27Z","timestamp":1707507567000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/97718-patterns-of-care-and-utilization-of-radiation-for-women-with-good-risk-ductal-carcinoma-in-situ-a-national-cancer-database-analysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,21]]},"references-count":27,"URL":"https:\/\/doi.org\/10.7759\/cureus.28223","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,21]]}}}